| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/06/2003 | CA2199830C Expression and export technology of proteins as immunofusins |
| 05/06/2003 | CA2153165C Recombinant anti-hiv antibody and process for preparing the same |
| 05/06/2003 | CA2126691C Gapped 2' modified oligonucleotides |
| 05/06/2003 | CA2094144C Methods and applications for efficient genetic suppressor elements |
| 05/06/2003 | CA2082160C Humanised and chimeric monoclonal antibodies |
| 05/06/2003 | CA2037431C Transposon consisting of a fragment of the r plasmid pcxm82b |
| 05/06/2003 | CA2031811C Toxoplasma gondii antigens, the preparation thereof and the use thereof |
| 05/06/2003 | CA2018676C Novel heteropolymeric protein production methods |
| 05/03/2003 | WO2003022863A1 Secreted and cell surface genes expressed in benign and malignant colorectal tumors |
| 05/03/2003 | WO2002048716A3 Differential phage capture proteomics |
| 05/02/2003 | EP1306672A2 Method of screening drug for hepatitis C |
| 05/02/2003 | EP1306446A1 Kits for extracting nucleic acid and method of extracting nucleic acid by using the kits |
| 05/02/2003 | EP1306441A1 Method of improving gene transfer efficiency into plant cells |
| 05/02/2003 | EP1306440A1 Method of improving gene transfer efficiency into plant cells |
| 05/02/2003 | EP1306439A1 Protein production with non-metabolizable expression indicator |
| 05/02/2003 | EP1306438A1 Novel carbonyl reductase, gene thereof and method of using the same |
| 05/02/2003 | EP1306437A2 Delta opioid receptor genes |
| 05/02/2003 | EP1306436A1 P53-dependent novel apoptosis-associated protein and method of screening apoptosis controlling agent |
| 05/02/2003 | EP1306435A1 Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin |
| 05/02/2003 | EP1306434A1 Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin |
| 05/02/2003 | EP1306433A1 Marker for detecting plant genome polymorphism with the use of transposable element and method of constructing the same |
| 05/02/2003 | EP1306432A1 Human ii type 5 alpha-reductase promoter gene and use thereof |
| 05/02/2003 | EP1306430A1 Process for producing recombined protein |
| 05/02/2003 | EP1306429A1 Method of screening ptp zeta activity promoter or inhibitor |
| 05/02/2003 | EP1306428A1 Dna synthase |
| 05/02/2003 | EP1306427A1 Method of proliferating natural killer cells |
| 05/02/2003 | EP1306385A1 Aequorin as a reporter gene in yeast |
| 05/02/2003 | EP1306384A1 Aequorin as a growth marker in yeast |
| 05/02/2003 | EP1306371A1 Cyclic imines |
| 05/02/2003 | EP1306005A1 Nonhuman animal models non-responsive to mycoplasma-origin lipoprotein/lipopeptide |
| 05/02/2003 | EP1305741A1 Online media exchange |
| 05/02/2003 | EP1305636A2 Screening method |
| 05/02/2003 | EP1305634A2 Fluorescence assay for gamma-secretase activity and inhibitors |
| 05/02/2003 | EP1305633A2 Peptide sequences comprising one or several protein binding units of the ena/vasp family, and uses thereof |
| 05/02/2003 | EP1305631A1 Detection of abnormalities leading to cervical malignancy |
| 05/02/2003 | EP1305630A1 A novel assay for determination of androgenic or anti-androgenic activity of a serum sample or a test compound |
| 05/02/2003 | EP1305628A2 Dielectrically-engineered microparticles |
| 05/02/2003 | EP1305627A2 Protein fragment complementation assay based on beta-lactamase |
| 05/02/2003 | EP1305626A2 Bio-probes and use thereof |
| 05/02/2003 | EP1305616A1 Method for analysing nucleic acids |
| 05/02/2003 | EP1305614A2 Biosensor arrays and methods |
| 05/02/2003 | EP1305595A2 Frozen tissue microarrays and methods for using the same |
| 05/02/2003 | EP1305450A2 Oligonucleotide library for detecting rna transcripts and splice variants that populate a transcriptome |
| 05/02/2003 | EP1305447A2 Nucleic acids and pathogenic e.coli proteins, and their uses |
| 05/02/2003 | EP1305439A2 Production of polyhydroxyalkanoates from polyols |
| 05/02/2003 | EP1305438A1 Improved virus like particles based on small envelope protein from hepatitis b (hbsag-s) |
| 05/02/2003 | EP1305437A2 Expression of biologically active polypeptides in duckweed |
| 05/02/2003 | EP1305436A2 Co-expression of recombinant proteins |
| 05/02/2003 | EP1305435A1 Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses |
| 05/02/2003 | EP1305434A2 A human disintegrin protein |
| 05/02/2003 | EP1305433A2 Methods for high-temperature hydrolysis of galactose-containing oligosaccharides in complex mixtures |
| 05/02/2003 | EP1305432A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
| 05/02/2003 | EP1305431A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
| 05/02/2003 | EP1305430A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
| 05/02/2003 | EP1305429A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
| 05/02/2003 | EP1305428A2 62088, a human nucleoside phosphatase family member and uses thereof |
| 05/02/2003 | EP1305427A1 19053, an atpase-like molecule and uses thereof |
| 05/02/2003 | EP1305426A2 25324, 50287, 28899, 47007 and 42967, transferase family members, and uses therefor |
| 05/02/2003 | EP1305425A2 Drug metabolizing enzymes |
| 05/02/2003 | EP1305423A2 Enhancement of industrial production by increasing substrate transport |
| 05/02/2003 | EP1305422A2 2,5-dkg permeases |
| 05/02/2003 | EP1305421A2 Enhanced 2-keto-l-gulonic acid production |
| 05/02/2003 | EP1305419A2 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 05/02/2003 | EP1305418A2 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 05/02/2003 | EP1305417A2 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof |
| 05/02/2003 | EP1305416A2 Identification of a novel glutamine transporter |
| 05/02/2003 | EP1305415A1 Protein inhibitor of apoptosis proteins |
| 05/02/2003 | EP1305414A2 Modified cea and uses thereof |
| 05/02/2003 | EP1305413A1 Therapeutic compounds |
| 05/02/2003 | EP1305412A2 Anthozoa derived chromo/fluoroproteins and methods for using the same |
| 05/02/2003 | EP1305411A1 Method of producing functional protein domains |
| 05/02/2003 | EP1305410A2 Insulin producing cell-line obtained by electrofusion |
| 05/02/2003 | EP1305409A2 Renal regulatory elements and methods of use thereof |
| 05/02/2003 | EP1305406A2 Modulation of gamma-secretase activity |
| 05/02/2003 | EP1305405A2 Methods of controlling gene expression and gene silencing |
| 05/02/2003 | EP1305404A2 Protein phosphatases |
| 05/02/2003 | EP1305403A2 Dna element promoter of transcription activity, active in human cells and general method for adjusting the activity thereof |
| 05/02/2003 | EP1305399A1 Bacillus subtilis var. chungkookjang producing high molecular weight poly-gamma-glutamic acid |
| 05/02/2003 | EP1305342A2 Human kininogen d5 domain polypeptides and their use |
| 05/02/2003 | EP1305341A1 Dog melanin-concentrating hormone receptor |
| 05/02/2003 | EP1305340A2 Sequences for integrin alpha-8 |
| 05/02/2003 | EP1305336A2 Therapeutic anti-melanoma compounds |
| 05/02/2003 | EP1305335A2 Novel eosinophil cationic proteins used in the treatment of asthmatic and allergic disorders |
| 05/02/2003 | EP1305334A1 Urocortin proteins and uses thereof |
| 05/02/2003 | EP1305331A1 Motor proteins and methods for their use |
| 05/02/2003 | EP1305039A2 Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof |
| 05/02/2003 | EP1304922A2 Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring |
| 05/02/2003 | EP1304921A2 Transgenic mice containing targeted gene disruptions |
| 05/02/2003 | EP1304920A2 Transgenic mice containing targeted gene disruptions |
| 05/02/2003 | EP1304916A1 Modification of plant resistance to diseases and/or pests |
| 05/02/2003 | EP1304915A1 Modification of lignin biosynthesis |
| 05/02/2003 | EP1151079A4 1-deoxy-d-xylulose-5-phosphate reductoisomerases, and methods of use |
| 05/02/2003 | EP1121459B1 Color compensation for temperature and electronic gains |
| 05/02/2003 | EP1036167B1 Nuclear targeting by means of streptococcal protein h |
| 05/02/2003 | EP1007675A4 Porcine mhc class i genes and uses thereof |
| 05/02/2003 | EP0986396A4 Prion protein modulator factor (ppmf) and prion resistant animals |
| 05/02/2003 | EP0983366B1 Dna encoding an arthropod chitin synthase |
| 05/02/2003 | EP0968283B1 Generation of diversity in combinatorial libraries |
| 05/02/2003 | EP0948544B1 Monovalent antibody fragments |
| 05/02/2003 | EP0932882B1 Proteome analysis for characterization of up- and down-regulated proteins in biological samples |